Publications

Elfandy H, Armenia J, Pederzoli F, Pullman E, Pertega-Gomes N, Schultz N, Viswanathan K, Vosoughi A, Blattner M, Stopsack KH et al..  2019.  Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate.. Mol Cancer Res. 17(2):446-456.

Labbé DP, Zadra G, Yang M, Reyes JM, Lin CY, Cacciatore S, Ebot EM, Creech AL, Giunchi F, Fiorentino M et al..  2019.  High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program.. Nat Commun. 10(1):4358.

Zadra G, Ribeiro CF, Chetta P, Ho Y, Cacciatore S, Gao X, Syamala S, Bango C, Photopoulos C, Huang Y et al..  2019.  Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer.. Proc Natl Acad Sci U S A. 116(2):631-640.

Giunchi F, Fiorentino M, Loda M.  2019.  The Metabolic Landscape of Prostate Cancer.. Eur Urol Oncol. 2(1):28-36.

Zadra G, Loda M.  2019.  When fat goes down, prostate cancer is on the ropes.. Mol Cell Oncol. 6(3):1595308.

Pettersson A, Gerke T, Penney KL, Lis RT, Stack EC, Pertega-Gomes N, Zadra G, Tyekucheva S, Giovannucci EL, Mucci LA et al..  2018.  MYC Overexpression at the Protein and mRNA Level and Cancer Outcomes among Men Treated with Radical Prostatectomy for Prostate Cancer.. Cancer Epidemiol Biomarkers Prev. 27(2):201-207.

Tyekucheva S, Bowden M, Bango C, Giunchi F, Huang Y, Zhou C, Bondi A, Lis R, Van Hemelrijck M, Andrén O et al..  2017.  Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer.. Nat Commun. 8(1):420.